Body composition and prevalence of left ventricular hypertrophy

被引:0
|
作者
Kuch, B
Hense, HW
Gneiting, B
Döring, A
Muscholl, M
Bröckel, U
Schunkert, H
机构
[1] Univ Munster, Bereich Klin Epidemiol, Inst Epidemiol & Sozialmed, Clin Epidemiol Unit, D-48129 Munster, Germany
[2] GSF Forschungszentrum Umwelt & Gesundheit, Inst Epidemiol, Munich, Germany
[3] Univ Regensburg, Dept Internal Med 2, D-8400 Regensburg, Germany
[4] Cent Hosp, Dept Internal Med 1, Augsburg, Germany
关键词
hypertrophy; fat-free mass; obesity; epidemiology;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Fat-free mass (FFM) has been proposed as an optimal normalization of left ventricular (LV) mass to body size. We sought to evaluate the novel FFM-based criteria of LV hypertrophy (LVH). Methods and Results-A population sample of 1371 men and women aged 25 to 74 years was examined by echocardiography and bioelectrical impedance analysis. Internal partition values for LVH were generated in a healthy population subgroup on the basis of LV mass divided by FFM and by the traditional indexations to body height, height(2 7), and body surface area. In contrast to the sex-specific criteria required by traditional indexations, the value of LV mass/FFM that divided individuals with and without LVH was identical for men and women (4.1 g/kg). Estimates of LVH prevalence varied significantly by type of indexation used, internally or externally derived cut points, and by population subgroups. Differences were pronounced among hypertensives and the obese. Thus, the application of LV mass/FFM more than halved the risk of LVH in obese versus nonobese women (odds ratio, 2.5; 95% confidence interval, 1.6 to 4.0) compared with criteria based on LV masskeight(2.7) (odds ratio, 5.5; 95% confidence interval, 3.6 to 8.3). Implications among hypertensives were less marked. Conclusions-Indexation of LV mass to FFM eliminates sex-specific LVH criteria. The proportion of individuals defined as having LVH using the new criteria deviate markedly from traditional indexations. Prospective investigations will be needed to identify the prognostic implications of different indexations, especially in subgroups such as the obese.
引用
收藏
页码:405 / 410
页数:6
相关论文
共 50 条
  • [31] Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors
    Mitsnefes, MM
    Daniels, SR
    Schwartz, SM
    Meyer, RA
    Khoury, P
    Strife, CF
    PEDIATRIC NEPHROLOGY, 2000, 14 (10-11) : 898 - 902
  • [32] Prevalence of left ventricular hypertrophy in end stage renal disease
    Baigam, Nahida
    Kalar, Musleh Uddin
    Qasim, Saeeda Fouzia
    Saeed, Arfa
    Alvi, Harris
    INTERNATIONAL JOURNAL OF COLLABORATIVE RESEARCH ON INTERNAL MEDICINE & PUBLIC HEALTH, 2013, 5 (06) : 368 - 376
  • [33] Left Ventricular Hypertrophy in Hypertensive Children and Adolescents: Predictors and Prevalence
    Kavey, Rae-Ellen W.
    CURRENT HYPERTENSION REPORTS, 2013, 15 (05) : 453 - 457
  • [34] Ankylosing Spondylitis Is Associated with Increased Prevalence of Left Ventricular Hypertrophy
    Midtbo, Helga
    Gerdts, Eva
    Berg, Inger Jorid
    Rollefstad, Silvia
    Jonsson, Roland
    Semb, Anne Grete
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (09) : 1249 - 1255
  • [35] The prevalence and predictors of left ventricular hypertrophy in patients with rheumatoid arthritis
    Nadir, M. A.
    George, J.
    Mackle, G.
    Pauriah, M.
    Struthers, A.
    SCOTTISH MEDICAL JOURNAL, 2011, 56 (01) : 56 - 56
  • [36] Prevalence of left ventricular hypertrophy: Some alternate thoughts - Reply
    Paoletti, E
    Cassottana, P
    Cannella, G
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (06) : 1148 - 1149
  • [37] High prevalence of left ventricular hypertrophy in subjects with refractory hypertension
    Armario, P.
    de la Sierra, A.
    Rey, R. Hernandezdel
    Oliveras, A.
    Poch, E.
    Larrousse, M.
    Roca-Cusachs, A.
    JOURNAL OF HYPERTENSION, 2008, 26 : S255 - S255
  • [38] Prevalence of left ventricular hypertrophy in a general population - The Tromso Study
    Schirmer, H
    Lunde, P
    Rasmussen, K
    EUROPEAN HEART JOURNAL, 1999, 20 (06) : 429 - 438
  • [39] What Is Left Ventricular Hypertrophy and Is There a Reason to Regress Left Ventricular Hypertrophy?
    Weir, Matthew R.
    Townsend, Raymond R.
    JOURNAL OF CLINICAL HYPERTENSION, 2009, 11 (08): : 407 - 410
  • [40] Left Ventricular Hypertrophy: New Indexation With Body Cell Mass
    Mascherini, Gabriele
    Petri, Cristian
    Galanti, Giorgio
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2018, 50 (05): : 190 - 190